Northpointe Capital’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
AIC
RA
MCM
PCMI
Northpointe Capital's NPTN Position: Q1 2019 in Review
Northpointe Capital sold out of NEOPHOTONICS CORP (NPTN) in Q1 2019, closing a stake of 256,045 shares — an estimated $1.66M sold.
Northpointe Capital first reported a position in NPTN in Q2 2013 and held it in 18 quarters. The position peaked at $18.6M in Q3 2016. 132 funds tracked by Wall St. Rank hold NPTN as of Q1 2019.
- Northpointe Capital reported no remaining NEOPHOTONICS CORP position as of Q1 2019 after selling out during the quarter.
- Northpointe Capital sold 256,045 NEOPHOTONICS CORP shares in Q1 2019, an estimated $1.66M.
- Northpointe Capital first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 18 quarters.
- Northpointe Capital's NEOPHOTONICS CORP position peaked at $18.6M in Q3 2016.
- 132 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2019.
Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.